Rankings
▼
Calendar
BBIO Q3 2018 Earnings — BridgeBio Pharma, Inc. Revenue & Financial Results | Market Cap Arena
BBIO
BridgeBio Pharma, Inc.
$14B
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$41M
Net Income
-$31M
EPS (Diluted)
$-0.34
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$38M
Free Cash Flow
-$39M
Stock-Based Comp.
$1M
← FY 2018
All Quarters
Q4 2018 →
